Green Fresh Biotechnology Co

Green Fresh Biotechnology Co Current Liabilities

The Current Liabilities of Green Fresh Biotechnology Co (1084.HK) as of Oct 29, 2026 is 656.05 M CNY. In the previous year, Current Liabilities was 981.31 M CNY — a change of -33.14% (lower).

Current Liabilities

656.05 MCNY

YoY

-33.14%

Last updated:

Current Liabilities of Green Fresh Biotechnology Co is 2025 656.05 M CNY. Current Liabilities of Green Fresh Biotechnology Co was 2024 981.31 M CNY. It decreases by -33.14% lower compared to the previous year.

The Green Fresh Biotechnology Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
326.21 M CNY
Jan 1, 2019
391.70 M CNY
Jan 1, 2020
497.57 M CNY
Jan 1, 2021
580.98 M CNY
Jan 1, 2022
1.26 B CNY
Jan 1, 2023
1.15 B CNY
Jan 1, 2024
981.31 M CNY
Jan 1, 2025
656.05 M CNY
The Green Fresh Biotechnology Co Current Liabilities history
YEARCurrent LiabilitiesYoY
656.05 MCNY-33.14%
981.31 MCNY-14.35%
1.15 BCNY-9.06%
1.26 BCNY+116.86%
580.98 MCNY+16.76%
497.57 MCNY+27.03%
391.70 MCNY+20.08%
326.21 MCNY+15.08%
283.46 MCNY+24.10%
228.42 MCNY-38.01%
368.50 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Green Fresh Biotechnology Co Stock analysis

What does Green Fresh Biotechnology Co do? Green Future Food Hydrocolloid Marine Science Co., Ltd. generates revenue through the production and sale of hydrocolloid products for food manufacturing. The company operates across five segments: agar-agar for jelly, carrageenan for confectionery and snacks, konjac products, blended products for meat, and milk powder sales. Its primary buyers include food manufacturers and confectionery companies seeking hydrocolloid ingredients for their products. The firm's business model relies on direct sales of these specialized food additives to industrial clients in the food processing sector. The agar-agar segment focuses on jelly production, while carrageenan targets confectionery and snack manufacturers. Konjac products serve as a key ingredient in various food applications, and blended products are tailored for meat processing. The milk powder segment provides an additional revenue stream through dairy product sales. All segments operate under the company's investment holding structure, with no external partners or third-party services mentioned in the business description. Revenue is derived from the sale of hydrocolloid-based food additives across multiple food industry applications. The company's product portfolio includes agar-agar, carrageenan, konjac, blended compounds, and milk powder, each serving distinct food manufacturing needs. Industrial clients purchase these products to enhance texture, stability, and quality in their final food products. Green Fresh Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Green Fresh Biotechnology Co stock

Current Liabilities of Green Fresh Biotechnology Co is 656.05 M CNY in 2025.

Current Liabilities of Green Fresh Biotechnology Co changed from 981.31 M CNY to 656.05 M CNY, representing a -33.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Green Fresh Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Green Fresh Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Green Fresh Biotechnology Co

All Key Metrics — Green Fresh Biotechnology Co